GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:890202) » Definitions » EBIT per Share

Solara Active Pharma Sciences (BOM:890202) EBIT per Share : ₹-88.41 (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solara Active Pharma Sciences EBIT per Share?

Solara Active Pharma Sciences's EBIT per Share for the three months ended in Sep. 2024 was ₹7.56. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-88.41.

During the past 12 months, the average EBIT per Share Growth Rate of Solara Active Pharma Sciences was -144.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Solara Active Pharma Sciences's EBIT per Share or its related term are showing as below:

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Solara Active Pharma Sciences was 6.60% per year. The lowest was -47.40% per year. And the median was -20.40% per year.

BOM:890202's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Solara Active Pharma Sciences's EBIT for the three months ended in Sep. 2024 was ₹363 Mil.


Solara Active Pharma Sciences EBIT per Share Historical Data

The historical data trend for Solara Active Pharma Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences EBIT per Share Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT per Share
Get a 7-Day Free Trial 62.86 81.05 -6.11 9.87 -99.83

Solara Active Pharma Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 -64.00 -36.50 4.53 7.56

Solara Active Pharma Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Solara Active Pharma Sciences's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

EBIT per Share(A: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-3899/39.057
=-99.83

Solara Active Pharma Sciences's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

EBIT per Share(Q: Sep. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=362.9/48.004
=7.56

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-88.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solara Active Pharma Sciences  (BOM:890202) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Solara Active Pharma Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences Business Description

Traded in Other Exchanges
Address
27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines